Preliminary Study of the Scale To Assess Ataxia and Neurologic Dysfunction (STAND)

University of South Florida30 enrolled

Overview

The objectives of this study are: * To validate the inter-rater and intra-rater reliability of a new scale for the assessment of ataxia and neurologic dysfunction (STAND) * To assess common constructs and correlation between STAND subscale items.

There are few validated, comprehensive rating scales for the assessment of ataxia severity. The development of a Scale To assess Ataxia and Neurologic Dysfunction (STAND) would examine and measure as many facets of ataxia as possible. Scale items to be measured include parkinsonism, timed gait analysis, dystonia, neuropathy and peripheral nerve weakness, as well as other areas of clinical manifestation for ataxia. This brief but thorough scale should yield a thorough measurement of ataxia.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Spinocerebellar Ataxia - All Sub-types Friedreich's Ataxia

Interventions

Ataxia rating scaleOTHER

Administer new rating scale for ataxia. This will be administered by two different raters on two separate occassions, 4 to 6 weeks apart.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Diagnosis of ataxia. * Male or female between 18 and 80 years of age. * Subject has voluntarily signed an IRB approved informed consent form to participate in the study after all relevant aspects of the study have been explained and discussed with the subject. Exclusion Criteria: * Any illness that in the investigator's opinion preclude participation in this study. * Subjects with a cardiac pacemaker * Legal incapacity or limited legal capacity.

Locations (1)

University of South Florida

Tampa, Florida, United States

Outcomes

Primary Outcomes

Inter- and intra-rater agreement

Assess agreement between raters (inter-rater agreement) and within raters (intra-rater agreement) through the evaluation of STAND total score, subtotals and individual variables using intraclass correlation coefficients (ICCs).

Time frame: 4 to 6 weeks

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.